BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32388531)

  • 21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Richter syndrome: an aggressive transformation.
    Streu E
    Oncol Nurs Forum; 2015 Mar; 42(2):200-3. PubMed ID: 25806888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periorbital non-Hodgkin's lymphoma after blunt trauma.
    Kriwalsky MS; Schroers R; Stricker I; Hollstein S; Kunkel M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):e56-9. PubMed ID: 20451833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
    Roberts E; Oncale M; Safah H; Schmieg J
    J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Richter Syndrome mimicking a lower limb cellulitis infection - a case report and review of the literature.
    César A; Calistru A; Pardal J; Magina S; Mota A; Azevedo F
    Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spotlight on rituximab in chronic lymphocytic leukemia, low-grade or follicular lymphoma, and diffuse large B-cell lymphoma.
    Keating GM
    BioDrugs; 2011 Feb; 25(1):55-61. PubMed ID: 21222497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-chronic lymphocytic leukemia showed triple transformation, to diffuse large B cell, CD20-negative, and T-cell neoplasm during ofatumumab treatment: a case report.
    Imataki O; Uemura M
    BMC Clin Pathol; 2018; 18():5. PubMed ID: 29796007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique case of concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and lymphomatoid papulosis in the same biopsy.
    Hibler J; Salavaggione AL; Martin A; Gru AA
    J Cutan Pathol; 2015 Apr; 42(4):276-84. PubMed ID: 25382820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia.
    O'Sullivan MJ; Kaleem Z; Bolger MJ; Swanson PE; Zutter MM
    Arch Pathol Lab Med; 2000 Jun; 124(6):907-9. PubMed ID: 10835534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two distinct histological Richter's transformations 23 years apart in a patient with chronic lymphocytic leukaemia.
    Thebo U; Millett RL; Elkon J; Haroun F
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30301728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
    Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
    Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.
    García Muñoz R; Izquierdo-Gil A; Muñoz A; Roldan-Galiacho V; Rabasa P; Panizo C
    Ann Hematol; 2014 Nov; 93(11):1879-87. PubMed ID: 24951124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Richter's syndrome: a case report.
    Olaniyi JA; Ibijola AA
    Med Princ Pract; 2009; 18(2):152-4. PubMed ID: 19204436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spotlight on rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Cvetković RS; Perry CM
    BioDrugs; 2006; 20(4):253-7. PubMed ID: 16831024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia arising at the site of herpes zoster and herpes simplex scars.
    Cerroni L; Zenahlik P; Kerl H
    Cancer; 1995 Jul; 76(1):26-31. PubMed ID: 8630873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group.
    Cramer P; Fink AM; Busch R; Eichhorst B; Wendtner CM; Pflug N; Langerbeins P; Bahlo J; Goede V; Schubert F; Döhner H; Stilgenbauer S; Dreger P; Kneba M; Böttcher S; Mayer J; Hallek M; Fischer K
    Leuk Lymphoma; 2013 Aug; 54(8):1821-2. PubMed ID: 23631654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.